- Home
- KODK vs RLAY Comparison
KODK vs RLAY Comparison
Compare KODK & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KODK
- RLAY
- Stock Information
- Founded
- KODK 1880
- RLAY 2015
- Country
- KODK United States
- RLAY United States
- Employees
- KODK N/A
- RLAY N/A
- Industry
- KODK Business Services
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- KODK Consumer Discretionary
- RLAY Health Care
- Exchange
- KODK Nasdaq
- RLAY Nasdaq
- Market Cap
- KODK 512.9M
- RLAY 490.3M
- IPO Year
- KODK N/A
- RLAY 2020
- Fundamental
- Price
- KODK $5.56
- RLAY $3.24
- Analyst Decision
- KODK
- RLAY Strong Buy
- Analyst Count
- KODK 0
- RLAY 11
- Target Price
- KODK N/A
- RLAY $18.40
- AVG Volume (30 Days)
- KODK 1.7M
- RLAY 1.6M
- Earning Date
- KODK 05-08-2025
- RLAY 05-05-2025
- Dividend Yield
- KODK N/A
- RLAY N/A
- EPS Growth
- KODK N/A
- RLAY N/A
- EPS
- KODK 0.52
- RLAY N/A
- Revenue
- KODK $1,041,000,000.00
- RLAY $7,679,000.00
- Revenue This Year
- KODK N/A
- RLAY $14.58
- Revenue Next Year
- KODK N/A
- RLAY N/A
- P/E Ratio
- KODK $11.30
- RLAY N/A
- Revenue Growth
- KODK N/A
- RLAY N/A
- 52 Week Low
- KODK $4.26
- RLAY $1.78
- 52 Week High
- KODK $8.24
- RLAY $10.72
- Technical
- Relative Strength Index (RSI)
- KODK 39.21
- RLAY 58.47
- Support Level
- KODK $5.44
- RLAY $2.75
- Resistance Level
- KODK $5.90
- RLAY $3.39
- Average True Range (ATR)
- KODK 0.23
- RLAY 0.20
- MACD
- KODK -0.05
- RLAY 0.04
- Stochastic Oscillator
- KODK 9.16
- RLAY 76.56
About KODK Eastman Kodak Company Common New
Eastman Kodak Co is a United States-based company. It operates through several business segments; Print, Brand, and Advanced Materials and Chemicals. The Print segment which derives the majority of revenue includes products like digital offset plate offerings and computer-to-plate imaging solutions, high-quality digital printing solutions using electrically charged toner-based technology, production press systems, consumables, inkjet components, software and services. Geographically, the company generates revenue from the United States, Canada, Europe, Middle East and Africa, Asia Pacific, and Latin America.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).